1. Home
  2. ALLO vs ATLO Comparison

ALLO vs ATLO Comparison

Compare ALLO & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$1.48

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$25.18

Market Cap

205.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLO
ATLO
Founded
2017
1903
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
252.9M
205.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ALLO
ATLO
Price
$1.48
$25.18
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
$8.27
N/A
AVG Volume (30 Days)
4.6M
23.5K
Earning Date
03-12-2026
01-23-2026
Dividend Yield
N/A
3.30%
EPS Growth
N/A
88.22
EPS
N/A
2.14
Revenue
N/A
$65,795,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$11.35
Revenue Growth
N/A
23.09
52 Week Low
$0.86
$16.09
52 Week High
$3.78
$24.96

Technical Indicators

Market Signals
Indicator
ALLO
ATLO
Relative Strength Index (RSI) 47.09 74.71
Support Level $1.54 $24.00
Resistance Level $1.83 $24.96
Average True Range (ATR) 0.13 0.62
MACD -0.00 0.14
Stochastic Oscillator 25.23 95.61

Price Performance

Historical Comparison
ALLO
ATLO

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

Share on Social Networks: